FOLD

Amicus Therapeutics, Inc.

1 day chart

About FOLD

Amicus Therapeutics, Inc. is a biotechnology company that is focused on discovering, developing, and delivering medicines for rare diseases. The Company's portfolio is Galafold (migalastat), which is the approved oral precision medicine for people living with Fabry disease. Galafold is designed to bind to and stabilize an endogenous alpha-galactosidase A (alpha-Gal A) enzyme in patients with genetic variants. Migalastat is approved under the trade name Galafold in the United States, European Union, United Kingdom and Japan. Its biologics program in its pipeline is Amicus Therapeutics GAA (AT-GAA), which is a clinical-stage treatment paradigm for Pompe disease. Pompe disease is a lysosomal disorder (LD) from deficiency in an enzyme, GAA. AT-GAA consists of a uniquely engineered rhGAA enzyme, ATB200, or cipaglucosidase alfa, with an optimized carbohydrate structure to enhance lysosomal uptake, administered in combination with AT2221 (miglustat) that functions as an enzyme stabilizer.

Buy US stocks in Australia starting with FOLD. Open an account and start investing today!

Market Capitalisation

$3.16B

Price-earnings ratio

Dividend yield

0.00%

Volume

1.27M

High today

$11.30

Low today

$10.93

Open price

$11.08

52-week high

$13.84

52-week low

$7.50

FOLD FAQs

Can I buy FOLD shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy FOLD shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Amicus Therapeutics, Inc.?

One share of Amicus Therapeutics, Inc. is valued at $11.17.

What is the ticker symbol for Amicus Therapeutics, Inc.?

The ticker symbol for Amicus Therapeutics, Inc. is FOLD.

How do I buy FOLD shares in Australia?

To buy FOLD stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in FOLD

What is the 52-week high for Amicus Therapeutics, Inc. stock?

The Amicus Therapeutics, Inc. 52-week high stock price is $13.84.

What is the 52-week low for Amicus Therapeutics, Inc. stock?

The Amicus Therapeutics, Inc. 52-week low stock price is $7.50.

What is the market capitalisation of Amicus Therapeutics, Inc. FOLD?

As of 31/05/2023 Amicus Therapeutics, Inc. has a market cap of $3.2B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.